Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Open access
Gokbuget, N., Dombret, H., Ribera, J.-M., Fielding, A. K., Advani, A., Bassan, R., Chia, V., Doubek, M., Giebel, S., Hoelzer, D., Ifrah, N., Katz, A., Kelsh, M., Martinelli, G., Morgades, M., OBrien, S., Rowe, J. M., Stieglmaier, J., Wadleigh, M., Kantarjian, H.·2016·Haematologica

Abstract

Adults with relapsed/refractory acute lymphoblastic leukemia have an unfavourable prognosis, which is influenced by disease and patient characteristics. To further evaluate these characteristics, a retrospective analysis of 1,706 adult patients with Ph-negative relapsed/refractory B-precursor acute lymphoblastic leukemia diagnosed between 1990-2013 was conducted using data reflecting the standard of care from 11 study groups and large centers in Europe and the United States. Outcomes included complete remission, overall survival, and realization of stem cell transplantation after salvage treatment. The overall complete remission rate after first salvage was 40%, ranging from 35%-41% across disease status categories (primary refractory, relapsed with or without prior transplant), and was lower after second (21%) and third or greater (11%) salvage. The overall complete remission rate was higher for patients diagnosed from 2005 onward (45%, 95% CI: 39%-50%). One- and three-year survival rates after first, second, and third or greater salvage were 26% and 11%, 18% and 6%, and 15% and 4%, respectively, and rates were 2%-5% higher among patients diagnosed from 2005. Prognostic factors included younger age, longer duration of first remission, and lower white blood cell counts at primary diagnosis. This large dataset can provide detailed reference outcomes for patients with relapsed/refractory Ph-negative B-precursor acute lymphoblastic leukemia. clinicaltrials.gov identifier: 02003612.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3324/haematol.2016.144311

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 227

Metadata

Authors
Gokbuget, N., Dombret, H., Ribera, J.-M., Fielding, A. K., Advani, A., Bassan, R., Chia, V., Doubek, M., Giebel, S., Hoelzer, D., Ifrah, N., Katz, A., Kelsh, M., Martinelli, G., Morgades, M., OBrien, S., Rowe, J. M., Stieglmaier, J., Wadleigh, M., & Kantarjian, H.
Venue
Haematologica
Published
2016-09-01
Volume
101
Issue
12
Pages
1524-1533
ISSN
  • 0390-6078 (ISSN-L)
  • 1592-8721
OpenAlex
W2516611622
Cited by
227
References
3
FWCI
20.56
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia. https://app.cochat.ai/papers/10.3324/haematol.2016.144311
The paper
Gokbuget, N., Dombret, H., Ribera, J.-M., Fielding, A. K., Advani, A., Bassan, R., Chia, V., Doubek, M., Giebel, S., Hoelzer, D., Ifrah, N., Katz, A., Kelsh, M., Martinelli, G., Morgades, M., OBrien, S., Rowe, J. M., Stieglmaier, J., Wadleigh, M., & Kantarjian, H. (2016). International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia. Haematologica. https://doi.org/10.3324/haematol.2016.144311

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.